Consumer Medication Information Focus of FDA Meeting on July 17

FDA’s Drug Safety and Risk Management Advisory Committee will meet July 17 in Gaithersburg, MD to discuss ways to improve the usefulness of consumer medication information (CMI). NCPIE’s Ray Bullman is scheduled to testify, based on written comments NCPIE submitted to FDA this week. After reviewing public policy initiatives to improve CMI, Bullman will outline a CMI research agenda. Copies of NCPIE’s comments are available upon request from